Start a live chat
1-800-870-4800
Building NAD+ from scratch —
the route the body
keeps in reserve.
Almost every discussion of NMN runs along a single road: the salvage route, where nicotinamide is recycled back toward NAD+. But that is not the only way the body reaches the molecule. There is a second route that builds NAD+ from scratch — from an amino acid — and understanding it puts the NMN story in its true context: as one road among several that all arrive at the same place.
I
The road that builds,
not the road that recycles.
The NMN story, told the usual way, is a story of recycling. NAD+ is used, broken down to nicotinamide, and sent back around: nicotinamide becomes NMN through NAMPT, NMN becomes NAD+ through NMNAT, and the cycle turns again. This recycling route — the Salvage Pathway — does most of the day-to-day work of keeping cells supplied, and the methyl housekeeping that accompanies it completes that loop. But recycling presumes there is already material in circulation. Something had to make the NAD+ in the first place.
That original manufacture is the work of a different route entirely: the de novo pathway — Latin for "from new." Rather than recycling an existing fragment, the de novo pathway builds NAD+ starting from tryptophan, an essential amino acid the body obtains from dietary protein. Through a series of steps known collectively as the kynurenine pathway, tryptophan is converted, stage by stage, into a molecule that can finally be assembled into NAD+. Where salvage turns a wheel, de novo lays down new track.
Naming this route matters because it reframes what NMN is. NMN sits on the recycling road — the efficient, short path that keeps a circulating pool topped up. The de novo pathway is the long road that creates the pool to begin with. Neither replaces the other; the body runs both, for different reasons. Seeing the full map, rather than the salvage road alone, is what places the precursor most people focus on into its real surroundings. For the molecule all these roads converge upon, the nature of NAD+ itself is the necessary background.
Recycling presumes
there is already material
in circulation.
Something had to make
the NAD+ first —
and that is the de novo road.
Three Roads to One Molecule
Every cell reaches NAD+
by more than one route.
NAD+ is important enough that the body maintains several ways of arriving at it, each starting from a different material. All biology described here is drawn from independent research that did not involve any specific Codeage product.
The from-scratch route. Starting with the essential amino acid tryptophan, the kynurenine pathway carries out a long sequence of conversions that ultimately yields a building block the cell can turn into NAD+. It is the most elaborate of the routes and the only one that creates the molecule from a non-vitamin starting material. Because it draws on tryptophan, it ties the supply of NAD+ to dietary protein and to the broader handling of that amino acid in the body.
The vitamin route. Niacin — nicotinic acid, one of the forms of vitamin B3 — enters through the Preiss-Handler pathway, a short sequence that converts dietary niacin into NAD+ in a handful of steps. It is the classical reason vitamin B3 has long been considered essential, and it sits between the elaborate de novo route and the rapid salvage route in both length and character.
The recycling route, and the one most NMN discussion lives on. Nicotinamide released as NAD+ is used is recaptured by NAMPT to form NMN, which NMNAT then completes into NAD+. It is the fastest and most economical of the routes, which is why adult cells lean on it so heavily for moment-to-moment supply. NMN sits one step from the finish on this road — the reason it occupies the position it does in the conversation.
II
Why the body keeps
a long road it rarely hurries down.
If the salvage route is so efficient, a fair question is why the body bothers maintaining the long de novo pathway at all. Part of the answer is that recycling can only redistribute what already exists; it cannot create supply from nothing. The de novo route provides exactly that — an ability to generate NAD+ from a dietary amino acid, independent of how much nicotinamide happens to be circulating. It is the foundational capacity beneath the recycling, a reserve the system can lean on when demand and supply fall out of step.
The de novo pathway also connects NAD+ to a much wider web of biology. Tryptophan is not used solely to make NAD+; it is a starting point for several molecules the body needs, and the kynurenine pathway through which de novo synthesis runs is studied across many areas of physiology. This means the from-scratch route to NAD+ is woven into how the body manages an essential amino acid as a whole — one more reminder that NAD+ biology does not sit in isolation but inside the larger fabric of metabolism.
For thinking about NMN, the lesson is one of proportion. The salvage road, where NMN lives, is the efficient everyday route — but it is not the whole supply system, and it is not the origin. Holding the de novo and Preiss-Handler routes in view alongside it keeps the picture honest: NMN is a well-placed molecule on the most-travelled road, not the sole source of the cofactor. All three roads converge on the same pool, and the body's reliance on each can shift with circumstance.
The De Novo Route, Step by Step
From an amino acid
to the shared pool.
The from-scratch road in three moments — where it begins, the long middle, and where it joins the route NMN also serves.
Moment 01 · Start
Tryptophan enters
The route begins with tryptophan, an essential amino acid drawn from dietary protein. Unlike the recycled fragments that feed the salvage road, this is raw material the body did not previously hold as part of the NAD+ pool — the genuine starting point of from-scratch synthesis.
Moment 02 · Build
The kynurenine pathway
Through a long sequence known as the kynurenine pathway, tryptophan is converted stage by stage into a building block suited to NAD+ assembly. It is the most elaborate of the routes, which is part of why the body reserves it rather than relying on it for rapid, everyday turnover.
Moment 03 · Converge
Into the shared NAD+ pool
The de novo road ends where the others do: the building block is assembled into NAD+, joining the same pool the salvage route — and NMN — feed. From the cell's point of view, NAD+ made from scratch is indistinguishable from NAD+ that was recycled. The roads differ; the destination does not.
The Biology in Numbers
What the map of NAD+
supply looks like.
3
Recognised routes to NAD+ — de novo, Preiss-Handler, and salvage — each from a different starting material
From scratch out of tryptophan, from the vitamin niacin, or by recycling nicotinamide through NMN. The body maintains all three, a redundancy that reflects how central the cofactor is to cellular life. Research describing these routes was conducted independently and did not involve any specific Codeage product.
1
Shared NAD+ pool that all three roads ultimately converge upon
However NAD+ is reached, it enters the same working supply. This convergence is why no single route — including the salvage road NMN sits on — can be regarded as the whole story. They are complementary contributors to one common reservoir, not competing alternatives.
1
Amino acid — tryptophan — that anchors the de novo route to dietary protein
The from-scratch road begins with a single essential amino acid the body cannot make for itself. That starting point links NAD+ supply to diet in a way the recycling route does not, and ties the kynurenine pathway into the broader handling of tryptophan across the body.
III
The whole map,
not the most-travelled road.
A series that has followed NMN through the enzymes that make it, the enzyme that completes it, the enzymes that consume the NAD+ it becomes, and the methyl housekeeping of the return has, until now, stayed on the recycling road. The de novo pathway is the piece that widens the frame from a single route to the full supply map. NMN belongs to the salvage road; the de novo road builds the cofactor from an amino acid; the Preiss-Handler road brings it from a vitamin. Three origins, one destination.
Held together, these routes make NMN's role clearer rather than smaller. The molecule sits at an advantageous spot on the most efficient, most-used road — which is exactly why it draws the attention it does. But efficiency on one road is not the same as being the origin of the supply, and a precise account says so. As with much of NAD+ biology, the finer detail — how heavily different tissues lean on de novo synthesis, and how that balance shifts across circumstances and over a lifetime — is still being mapped, and the account given here reflects a field that continues to fill in its own picture.
That fuller map is one expression of Cellular Longevity — Pillar 03 of The Longevity Code, the dimension of the system built around NAD+ biology and the science of how cells sustain themselves across time. Knowing that the body can build the cofactor from scratch, recycle it efficiently, and draw it from a vitamin is to see the depth of the system NMN is one part of.
Three origins,
one destination.
NMN sits on the most-travelled road —
but it is not
the whole map.
Codeage · Pillar 03 · Cellular Longevity
Built for the
cellular long game.
Cellular Longevity is Pillar 03 of The Longevity Code — the dimension of the system built around NAD+ biology, mitochondrial health, and the science of cellular aging.
Explore Cellular Longevity →Research and studies referenced throughout this article were conducted independently and did not involve any Codeage products. Statements have not been evaluated by the FDA. Codeage products are not intended to diagnose, treat, cure, or prevent any disease.
